Healthcare & Life Sciences
Cell-Easy
France
aliveseries-a
series-a
Stage
About
Cell-Easy is a contract development and manufacturing organization (CDMO) that produces ready-to-inject adipose-derived allogeneic stem cell products under cGMP conditions, supporting preclinical and clinical drug development with regulatory-compliant, scalable supply inspected by the French ANSM.
Explore Cell-Easy's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.